Blog

Jul 7, 2024, 13:29

Iván R. González: Recent research reveals that cancer treatments can activate dormant tumor cells in the lung

Iván R. González, Medical Oncologist at Comprehensive Oncology Center, Hospital Ángeles Puebla, shared a post on X:

“Recent research reveals that cancer treatments can activate dormant tumor cells in the lung, triggering metastasis months or years after initial treatment.

Disseminated tumor cells (DTCs) remaining dormant can awaken due to therapy-induced tissue damage.
Post-treatment inflammation and changes in the microenvironment are crucial for this process.
Developing strategies to inhibit this awakening is vital to reduce metastatic recurrence and enhance treatment effectiveness.

Understanding how oncologic treatments can reactivate dormant tumor cells in the lung, triggering metastasis, is essential for improving clinical outcomes. Research into post-treatment inflammation and microenvironmental changes is pivotal in this context. Developing effective strategies to mitigate this risk is crucial to reduce recurrence and optimize cancer management.”

Read further.
Source: Iván R. González/X

cancer Cancer Management cancer recurrence Cancer research cancer treatments clinical outcomes Comprehensive Oncology Center Disseminated tumor cells dormant tumor cells Hospital Ángeles Puebla Iván R. González Lung cancer metastasis metastatic recurrence microenvironment OncoDaily Oncology post-treatment inflammation

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage